ADGM Adagio Medical Holdings, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2006986 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE9.6%
ROA2.7%
ROIC (approx.)-89.9%
Asset turnover0.00x
Leverage & solvency
Liabilities / assets38.5%
Debt / equity0.11x
Current ratio0.90x
Interest coverage-5.77x
Cash quality & payout
Operating cash flow / net income-22.06x
Accruals ratio61.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q3*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Cost of revenue | — | — | — | $58,000 | $31,000 | $342,000 | $253,000 | — |
| Gross profit | — | — | — | -$58,000 | -$31,000 | -$342,000 | -$253,000 | — |
| R&D expense | $1.80M | $2.45M | $2.74M | $2.23M | $2.77M | $1.97M | $3.66M | — |
| SG&A expense | $2.57M | $2.48M | $2.46M | $1.68M | $2.92M | $2.40M | $3.48M | — |
| Operating income | -$4.37M | -$4.93M | -$5.20M | -$3.97M | -$5.72M | -$4.72M | -$7.40M | — |
| Interest expense | $843,000 | $805,000 | $778,000 | $775,000 | $749,000 | $720,000 | $662,000 | — |
| Net income | $17.84M | -$6.72M | -$7.00M | -$3.31M | -$10.12M | -$3.95M | -$7.71M | -$8.23M |
| EBITDA | -$4.17M | -$4.73M | -$4.99M | -$3.73M | -$5.52M | -$4.52M | -$7.13M | — |
| EPS (basic) | 2.40 | -0.30 | -0.31 | — | -19.73 | -0.26 | -0.50 | -8.34 |
| EPS (diluted) | -5.13 | -0.30 | -0.31 | — | -19.73 | -0.35 | -0.51 | — |
| Weighted avg. shares (diluted) | 833,254 | 22.21M | 22.21M | — | 512,718 | 15.38M | 15.38M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3.10M | $7.74M | $12.91M | $17.11M | $4.67M | $8.20M | $12.96M | $28.26M |
| Receivables | — | — | — | — | — | — | $1,000 | $90,000 |
| Inventory | $2.72M | $1.99M | $1.60M | $1.67M | $1.55M | $1.84M | $2.31M | $4.14M |
| Current assets | $6.91M | $10.69M | $15.86M | $20.08M | $8.14M | $12.23M | $17.37M | $35.03M |
| PP&E, net | $939,000 | $1.13M | $1.32M | $1.53M | $1.70M | $1.88M | $2.09M | $1.57M |
| Goodwill | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $13.97M | $44.29M |
| Intangibles | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $6.97M | $26.06M |
| Total assets | $29.86M | $33.88M | $39.31M | $43.25M | $31.55M | $35.88M | $41.34M | $107.20M |
| Current liabilities | $7.72M | $7.56M | $8.57M | $8.23M | $9.70M | $4.88M | $6.01M | $7.92M |
| Long-term debt | $2.01M | $24.84M | $22.87M | $21.04M | $21.19M | $16.95M | $17.65M | $13.75M |
| Total debt | $2.01M | $24.84M | $22.87M | $21.04M | $21.19M | $16.95M | $17.65M | $13.75M |
| Total liabilities | $11.50M | $34.30M | $33.58M | $30.85M | $32.86M | $27.21M | $28.94M | $30.64M |
| Shareholders' equity | $18.36M | -$415,000 | $5.72M | $12.40M | -$1.31M | $8.67M | $12.40M | $76.56M |
| Net debt | -$1.08M | $17.10M | $9.96M | $3.94M | $16.52M | $8.74M | $4.69M | -$14.51M |
| Shares outstanding | 889,644 | 22.21M | 22.21M | 740,348 | 15.38M | 15.38M | 15.38M | 14.54M |
| Cash flow statement | ||||||||
| Operating cash flow | -$4.61M | -$5.26M | -$4.13M | -$4.14M | -$3.01M | -$4.66M | -$7.21M | — |
| Capital expenditure | $4,000 | $6,000 | $2,000 | -$491,000 | $520,000 | $10,000 | $335,000 | — |
| Free cash flow | -$4.61M | -$5.27M | -$4.13M | -$3.65M | -$3.53M | -$4.67M | -$7.55M | — |
| Investing cash flow | -$4,000 | -$6,000 | -$2,000 | $491,000 | -$520,000 | -$10,000 | -$335,000 | — |
| Depreciation & amortization | $200,000 | $200,000 | $210,000 | $237,000 | $200,000 | $200,000 | $271,000 | — |
| Stock-based compensation | $218,000 | $479,000 | $389,000 | $890,000 | $137,000 | $234,000 | $218,000 | — |
Free plan shows the latest 8 periods; Pro shows all 12 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.